Heart failure. Heart failure
Conditions
Interventions
In the intervention group, continuous administration will start with an initial dose of 0.1 mg per kilogram of body weight per hour, and the drug dose can be doubled every 2 hours, with a maximum dose
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 28 Days
Inclusion criteria
Inclusion criteria: All term newborn boys and girls, diagnosed with heart failure
Exclusion criteria
Exclusion criteria: Neonate with an age of more than 28 days, a birth weight of less than 1000 grams, severe electrolyte disorders and the presence of shock symptoms are excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart failure. Timepoint: Pulmonary function indicators and hemodynamic responses of infants will be reported every 4 hours and urinary output every 6 hours and at the end of every 48 hours after treatment with an average score. Method of measurement: Echocardiography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment of heart failure. Timepoint: Pulmonary function indicators and hemodynamic responses of infants will be reported every 4 hours and urinary output every 6 hours and at the end of every 48 hours after treatment with an average score. Method of measurement: Echocardiography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Ahmadipour
Kerman University of Medical Sciences
Outcome results
None listed